Glioblastoma (GBM) is the most common brain cancer among adults and patients and has an overall survival (OS) of 15 months. Nowadays brain tumours are not taken in evaluation in relation to the brain area in which they are located. Recent studies have demonstrated that their prognosis is not independent of the structural organisation of the brain: in particular, white matter fibres disconnection degrees can be considered as a prognosis biomarker. The present invention refers to an algorithm for determining a new prognostic index of a brain tumour and it has been already implemented in a software with a user-friendly graphical interface (GUI). The method provides an indirect estimate of the damage that the tumour causes in patients, through data analysis comparison. The prognostic index, together with OS proves how different tumours in different brain areas can cause a peculiar damage, affecting the patient’s prognosis.

TRL (Technology Readiness Level)

TRL 5 / 9

Inventors

Maurizio Corbetta

Alessandro Salvalaggio

Lorenzo Pini

Download the brochure

  • Estimation of insulin sensitivity from CGM and subcutaneous insulin delivery in type 1 diabetes

    In the last 15-20 years new tools in diabetes therapy have emerged such as Continuous Glucose Monitoring (CGM) and Continuous Subcutaneous Insulin Infusion (CSII) which are destined to substitute Self Monitored Blood Glucose (SMBG) and Multiple Daily Injection (MDI) technologies...

  • Enhanced Multiplexing in Single-Cell Imaging Using 2D Nanolabels

    Single-cell analysis is essential for understanding complex biological systems, but conventional methods like flow cytometry are constrained by spectral overlap and limited detection channels. While mass cytometry (CyTOF) addresses these issues using metal isotopes, its multiplexing capacity is capped by...

  • Matrices for in vitro tumor tissues allow to test antineoplastic drugs and protocols

    Disclosed is a 3D matrices for in vitro growth of tumor tissues. Need to prune the system variables using faster and cheaper in vitro assays in order to design the in vivo experimentation on a smaller number of animals, obtaining...

Subscribe to newsletter

Follow the activities promoted by UniSMART Foundation